Literature DB >> 19240146

Topo2008: DNA topoisomerases in biology and medicine.

Tony Maxwell, Andy Bates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240146      PMCID: PMC2647289          DOI: 10.1093/nar/gkp072

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
The DNA topoisomerases are a group of fascinating enzymes that play an essential but dangerous game with DNA. They break and rejoin either one or both strands of the double helix to solve the problems of tangling and linking that occur as a result of DNA manipulations (replication, transcription and recombination) in all cells. This basic problem with the DNA structure was recognized by Watson and Crick almost as soon as the double helix was described (1). As the parental DNA strands are separated at a replication fork, the double-helical turns are compressed and overwound ahead of the fork; the resulting torsional stress will prevent further replication if it is not relieved. This overwinding corresponds to positive supercoiling. Alternatively, any rotation of the replication fork leads to interwinding of the replicated regions, ultimately resulting in linking (catenation) of the daughter chromosomes, which must be removed if partition is to occur without breaking the DNA (2). Transcription can also result in the generation of both positive and negative supercoiling (3), and other processes, particularly recombination, can lead to the knotting of DNA strands. These complexities of double-helical DNA are grouped together under the label of DNA topology (4). The topological problems of the DNA helix must have arisen very early in evolution, as soon as DNA genomes became long enough that a simple rotation of the entire molecule to remove supercoiling became impracticable. The only viable solution to these difficulties is to untwist, unlink and unknot the DNA by breaking one or both strands, permitting strands to pass through one another or allowing rotation at the break point. These strategies are adopted by the different classes of topoisomerase enzymes, discovered during the 1970s. The type I enzymes break and rejoin one strand of the helix, and either pass single strands through one another (type IA) or allow one broken end to rotate about the intact strand (type IB). Type I enzymes can remove supercoiling from DNA. In contrast, type II topoisomerases pass one double-helical segment through a double-stranded break in another, in an ATP-dependent reaction, and can thus unlink (decatenate) linked chromosomes, and remove knots. One subset of these enzymes, DNA gyrases, can introduce negative supercoiling (unwinding) into DNA. Most cell types express a suite of topoisomerase enzymes to regulate the topology of their DNA. However, these manipulations of the DNA helix come at a cost; the broken DNA strands must be efficiently rejoined to avoid serious consequences for the cell. The hijacking of topoisomerase mechanisms to produce stable single-stranded and, particularly, double-stranded breaks is a feature of a wide variety of natural and synthetic chemotherapeutic agents, making the topoisomerase enzymes important drug targets (5,6). During the 1990s, there were regular meetings on DNA topoisomerases in New York and Amsterdam. However, in recent years these meetings lapsed and we lacked a regular forum to discuss issues concerned with DNA topology and topoisomerases. Happily, Nynke Dekker, Paola Arimondo and Mary-Ann Bjornsti organized an excellent topoisomerase meeting in Fréjus, France in 2007. This re-established the momentum for similar meetings in the future, including Topo2008, which was held last year in Norwich, UK. Tremendous advances are being made in this field, which continues to be a fascinating and vibrant research area. Topics at the meeting ranged from discussions of the intricacies of DNA knotting to the translation of fundamental work on topoisomerases into drug discovery. This issue of NAR contains a special collection of Surveys and Summaries that cover the field of DNA topology and DNA topoisomerases and reflect the content of the Norwich meeting. Zechiedrich and colleagues discuss how misregulation of topology can lead to cellular dysfunction and consider how cells can prevent such topological problems (7). The control of supercoiling in bacterial cells has been extensively studied; Dorman and Corcoran discuss such studies and the effects of supercoiling on bacterial virulence and infectious diseases (8). Gadelle and Forterre review the origins and phylogenies of these enzymes and suggest that they originated in an ancestral virosphere (9). Mondragón and colleagues review structural work on type I enzymes, which has led to a deeper understanding of their reaction mechanisms (10). A key feature of many type I and type II enzymes is that they require Mg2+ ions in their reaction mechanisms. Sissi and Palumbo discuss the role of Mg2+ ions in topoisomerase structure and function, in particular, a proposed two metal ion mechanism for DNA cleavage (11). DNA cleavage in type II enzymes occurs at a region of the enzyme known as the ‘DNA gate’, and Collins et al. describe the use of single-molecule fluorescence energy transfer experiments to probe the dynamics of the DNA gate of type II topoisomerases (12). The double-strand break mechanism for type II enzymes has important implications for the role of topoisomerase II in eukaryotic cells, and Roca discusses the implications of this mechanism in the context of eukaryotic chromatin structure (13). Bacterial topoisomerase I is a potential, though currently unexploited, target for antibacterial agents; Tse-Dinh discusses screening for novel agents that target this enzyme (14). Deweese and Osheroff consider the DNA breakage–reunion reaction of type II enzymes and how compounds that stabilize the topoisomerase II cleavage complex can act as cytotoxic agents and be utilized as anti-cancer drugs (15). This collection of reviews illustrates the breadth of research work being carried out in the DNA topology/topoisomerase area, and also highlights some of the unsolved questions that remain. We would like to thank the authors who both participated in the meeting (Topo2008) and contributed to this excellent set of reviews, which will hopefully stimulate further enthusiasm for this field. We anticipate that the next meeting in this series will take place in 2010 in the USA.
  14 in total

1.  Genetical implications of the structure of deoxyribonucleic acid.

Authors:  J D WATSON; F H CRICK
Journal:  Nature       Date:  1953-05-30       Impact factor: 49.962

2.  Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli.

Authors:  E L Zechiedrich; N R Cozzarelli
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

Review 3.  Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.

Authors:  Y-C Tse-Dinh
Journal:  Infect Disord Drug Targets       Date:  2007-03

Review 4.  The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

Review 5.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

Review 6.  Analysis of the eukaryotic topoisomerase II DNA gate: a single-molecule FRET and structural perspective.

Authors:  Tammy R L Collins; Gordon G Hammes; Tao-Shih Hsieh
Journal:  Nucleic Acids Res       Date:  2009-01-20       Impact factor: 16.971

Review 7.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

Review 8.  The why and how of DNA unlinking.

Authors:  Zhirong Liu; Richard W Deibler; Hue Sun Chan; Lynn Zechiedrich
Journal:  Nucleic Acids Res       Date:  2009-02       Impact factor: 16.971

Review 9.  Effects of magnesium and related divalent metal ions in topoisomerase structure and function.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Nucleic Acids Res       Date:  2009-02-02       Impact factor: 16.971

Review 10.  Bacterial topoisomerase I as a target for discovery of antibacterial compounds.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.